Literature DB >> 21855705

Surgical approaches to the treatment of obesity: bariatric surgery.

Brian R Smith1, Phil Schauer, Ninh T Nguyen.   

Abstract

As the obesity epidemic continues to grow in the Unites States, so does the search for the ideal nonsurgical or surgical solution. Bariatric surgery continues to be the most sustainable form of weight loss available to morbidly obese patients. In addition, bariatric surgery has established an acceptable safety profile with respect to morbidity and mortality. With the number of elective bariatric cases growing in recent years, it is unsurprising that results have improved and better data are emerging regarding improvement of obesity-related comorbid conditions. Additionally, ample evidence suggests that bariatric surgery may increase longevity, particularly through reducing cardiovascular deaths. Although the specific mechanisms involved in the remission of these medical conditions remain to be fully elucidated, it has become clear that bariatric surgery has established a significant and firm role in the treatment of medical comorbidities that result directly from obesity. However, until commercial insurance carriers provide improved coverage for bariatric surgery, patient access to these treatments will remain limited.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21855705     DOI: 10.1016/j.mcna.2011.06.010

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  15 in total

1.  Liver abscess as a complication of laparoscopic gastric banding bariatric surgery.

Authors:  Danon Garrido; Larry M Bush
Journal:  Surg Infect (Larchmt)       Date:  2013-07-17       Impact factor: 2.150

2.  Enterotomy closure using knotless and barbed suture in laparoscopic upper gastrointestinal surgeries.

Authors:  Therese Bautista; Asim Shabbir; Jaideepraj Rao; Jimmy So; Koji Kono; Pradeep Durai
Journal:  Surg Endosc       Date:  2015-07-15       Impact factor: 4.584

3.  Comparing Medical Costs and Use After Laparoscopic Adjustable Gastric Banding and Roux-en-Y Gastric Bypass.

Authors:  Kristina H Lewis; Fang Zhang; David E Arterburn; Dennis Ross-Degnan; Matthew W Gillman; J Frank Wharam
Journal:  JAMA Surg       Date:  2015-08       Impact factor: 14.766

4.  Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass: a single center experience with 2 years follow-up.

Authors:  Maher El Chaar; Nadine Hammoud; George Ezeji; Leonardo Claros; Maureen Miletics; Jill Stoltzfus
Journal:  Obes Surg       Date:  2015-02       Impact factor: 4.129

5.  Reoperative Surgery for Management of Early Complications After Gastric Bypass.

Authors:  Toms Augustin; Ali Aminian; Héctor Romero-Talamás; Tomasz Rogula; Philip R Schauer; Stacy A Brethauer
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

6.  A meta-analysis: to compare the clinical results between gastric bypass and sleeve gastrectomy for the obese patients.

Authors:  Xuechao Yang; Guang Yang; Wensheng Wang; Guoqing Chen; Hua Yang
Journal:  Obes Surg       Date:  2013-07       Impact factor: 4.129

Review 7.  Bariatric surgery: the challenges with candidate selection, individualizing treatment and clinical outcomes.

Authors:  K J Neff; T Olbers; C W le Roux
Journal:  BMC Med       Date:  2013-01-10       Impact factor: 8.775

Review 8.  A complications-based clinical staging of obesity to guide treatment modality and intensity.

Authors:  Sunil Daniel; Taraneh Soleymani; W Timothy Garvey
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-10       Impact factor: 3.243

9.  Older adults fighting obesity with bariatric surgery: Benefits, side effects, and outcomes.

Authors:  Cindy L Marihart; Ardith R Brunt; Angela A Geraci
Journal:  SAGE Open Med       Date:  2014-04-23

10.  Suitability of administrative claims databases for bariatric surgery research - is the glass half-full or half-empty?

Authors:  Xiaojuan Li; Kristina H Lewis; Katherine Callaway; J Frank Wharam; Sengwee Toh
Journal:  BMC Med Res Methodol       Date:  2020-09-07       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.